PET and SPECT in epilepsy: A critical review

Molecular imaging with ictal and interictal single-photon emission computed tomography (SPECT) as well as positron emission tomography (PET) rank among the established functional imaging tests for the presurgical evaluation of epileptic onset zone in patients with intractable partial epilepsy. In temporal lobe epilepsy the sensitivity of these methods was shown to be excellent, in particular if a multimodal platform is used, which combines the functional imaging with the additional morphological information of magnetic resonance imaging (MRI), but was lower in extra temporal lobe epilepsy. Functional imaging with SPECT and PET reflects seizure related changes of cerebral perfusion, glucose-metabolism and neuroreceptor status. In this review the usefulness of SPECT and PET imaging in clinical routine in epilepsy as well as the role of different neuroreceptor PET-tracer, which were used in epilepsy are discussed. The use of perfusion SPECT tracer allows the investigation of ictal activations, but the low temporal resolution of ictal perfusion SPECT often results in the detection of both the ictal onset zone as well as the propagation pathways, an area that has not always need to be resected in order to render a patient seizure free. The additional use of interictal PET with fluorine-18 fluorodeoxyglucose which measures regional cerebral metabolism or interictal perfusion SPECT enhance the informational value of ictal SPECT and were shown to be important tools to better define the ictal onset and surround inhibition zones. In recent years PET imaging of different cerebral neuroreceptor-systems inter alia GABA(A) receptors, serotonin receptors (5-HT(1A)), opioid receptors as well as dopamine receptors was used to investigate the neurochemical basis of epilepsy, the role of these neurotransmitters for the epileptogenesis as well as the spread of epileptic activity during seizures and partially entered in clinical routine. Currently some of these radioligands are also used to investigate new treatment approaches.

[1]  A. Drzezga,et al.  18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  Frode Willoch,et al.  Imaging of opioid receptors in the central nervous system , 2007, Brain : a journal of neurology.

[3]  Alan A. Wilson,et al.  Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography , 1991, Annals of neurology.

[4]  G. Sedvall,et al.  IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI , 1988, The Lancet.

[5]  G F Morgan,et al.  SPECT brain imaging in epilepsy: a meta-analysis. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Ivanka Savic,et al.  [11C]Flumazenil Positron Emission Tomography Visualizes Frontal Epileptogenic Regions , 1995, Epilepsia.

[7]  O Muzik,et al.  Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy , 2000, Neurology.

[8]  P. Dupont,et al.  Comparative analysis of MR imaging, Ictal SPECT and EEG in temporal lobe epilepsy: a prospective IAEA multi-center study , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  G. Mathern,et al.  Epilepsia , 1991, NEURO FUNDAMENTAL.

[10]  E. Borrelli,et al.  Neuroprotective Role of Dopamine Against Hippocampal Cell Death , 2000, The Journal of Neuroscience.

[11]  G. Muscettola,et al.  Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. , 1991, European journal of pharmacology.

[12]  B. Brinkmann,et al.  Subtraction peri-ictal SPECT is predictive of extratemporal epilepsy surgery outcome , 2000, Neurology.

[13]  Jerome Engel,et al.  Introduction to temporal lobe epilepsy , 1996, Epilepsy Research.

[14]  I. Savic,et al.  Cortical Benzodiazepine Receptor Changes are Related to Frequency of Partial Seizures: A Positron Emission Tomography Study , 1996, Epilepsia.

[15]  M. Richardson,et al.  Central benzodiazepine/gamma-aminobutyric acid A receptors in idiopathic generalized epilepsy: an [11C]flumazenil positron emission tomography study. , 1997, Epilepsia.

[16]  F. Sharbrough,et al.  Subtraction SPECT Coregistered to MRI in Focal Malformations of Cortical Development: Localization of the Epileptogenic Zone in Epilepsy Surgery Candidates , 2004, Epilepsia.

[17]  C. Chung,et al.  Frontal lobe epilepsy: Clinical characteristics, surgical outcomes and diagnostic modalities , 2008, Seizure.

[18]  P. Lomax,et al.  Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans. , 1986, Advances in neurology.

[19]  T. O'Brien.  SPECT: methodology. , 2000, Advances in neurology.

[20]  I G Zubal,et al.  Sensitivity and specificity of quantitative difference SPECT analysis in seizure localization. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  V J Cunningham,et al.  Investigation of the opioid system in absence seizures with positron emission tomography. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[22]  Peter Herscovitch,et al.  PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy , 1992, Epilepsy Research.

[23]  M. Starr,et al.  Anticonvulsant effect of striatal dopamine D2 receptor stimulation: Dependence on cortical circuits? , 1991, Neuroscience.

[24]  R P Lesser,et al.  Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. , 1997, Annals of neurology.

[25]  C. Binnie,et al.  Clinical Value of “Ictal” FDG‐Positron Emission Tomography and the Routine Use of Simultaneous Scalp EEG Studies in Patients with Intractable Partial Epilepsies , 1998, Epilepsia.

[26]  Markus Piel,et al.  Decreased Dopamine D2/D3‐Receptor Binding in Temporal Lobe Epilepsy: An [18F]Fallypride PET Study , 2006, Epilepsia.

[27]  O Muzik,et al.  Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome , 2001, Neurology.

[28]  R. Lesser,et al.  Imaging of δ‐ and μ‐opioid receptors in temporal lobe epilepsy by positron emission tomography , 1997 .

[29]  D. Prince,et al.  Dopamine modulates a Ca2+-activated potassium conductance in mammalian hippocampal pyramidal cells , 1982, Nature.

[30]  Alan A. Wilson,et al.  Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy , 1988, Annals of neurology.

[31]  Andreas Schulze-Bonhage,et al.  Ictal Pleasant Sensations: Cerebral Localization and Lateralization , 2004, Epilepsia.

[32]  J C Froment,et al.  Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. , 1998, Brain : a journal of neurology.

[33]  Val J Lowe,et al.  The Usefulness of Subtraction Ictal SPECT Coregistered to MRI in Single‐ and Dual‐headed SPECT Cameras in Partial Epilepsy , 2002, Epilepsia.

[34]  F. Mauguière,et al.  PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. , 2008, Brain : a journal of neurology.

[35]  I Savic,et al.  In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[36]  David J. Brooks,et al.  Central Benzodiazepine/γ‐Aminobutyric AcidA Receptors in Idiopathic Generalized Epilepsy: An [11C]Flumazenil Positron Emission Tomography Study , 1997 .

[37]  Alexander Hammers,et al.  Upregulation of opioid receptor binding following spontaneous epileptic seizures. , 2007, Brain : a journal of neurology.

[38]  D. Brooks,et al.  Focal cortical release of endogenous opioids during reading induced seizures , 1998, The Lancet.

[39]  S. Tanada,et al.  Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  Patrick Dupont,et al.  The use of SPECT and PET in routine clinical practice in epilepsy , 2007, Current opinion in neurology.

[41]  K. Lindahl-Kiessling,et al.  USE AND ABUSE OF ELECTROENCEPHALOGRAPHY. , 1964, Lancet.

[42]  Ingmar Rosén,et al.  Does SISCOM Contribute to Favorable Seizure Outcome after Epilepsy Surgery? , 2007, Epilepsia.

[43]  M. Han,et al.  Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. , 1999, AJNR. American journal of neuroradiology.

[44]  François Mauguière,et al.  Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG , 2004, NeuroImage.

[45]  Christer Halldin,et al.  Preparation of highly specific radioactivity [18F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. , 2005, Nuclear medicine and biology.

[46]  S. Gambhir,et al.  Incidental detection of a single brain metastasis from breast carcinoma during Tc-99m MIBI scintimammography. , 2001, Clinical nuclear medicine.

[47]  François Mauguière,et al.  5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study. , 2004, Brain : a journal of neurology.

[48]  M. Sasaki,et al.  Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: A comparison with IMP SPECT and FDG PET , 2006, Nuclear medicine communications.

[49]  A. C. Santos,et al.  Interictal hyperemia correlates with epileptogenicity in polymicrogyric cortex , 2008, Epilepsy Research.

[50]  A. Catafau,et al.  Brain SPECT in clinical practice. Part I: perfusion. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[51]  C. Jack,et al.  Subtraction ictal SPECT co‐registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus , 1998, Neurology.

[52]  O. Witte,et al.  Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy , 1996, Neurology.

[53]  Ronald Boellaard,et al.  Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner , 2007, Physics in medicine and biology.

[54]  G. Blomqvist,et al.  Cortical Benzodiazepine Receptor Binding in Patients with Generalized and Partial Epilepsy , 1990, Epilepsia.

[55]  T. Yousry,et al.  Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control , 2001, Nuclear medicine communications.

[56]  西沢 貞彦.  Regional dynamics of N-isopropyl-([123]I)p-iodo-amphetamine in human brain , 1991 .

[57]  John S. Duncan,et al.  Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalo- hippocampectomy, using positron emission tomography , 1994, Epilepsy Research.

[58]  W. van Paesschen,et al.  Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. , 1997, Brain : a journal of neurology.

[59]  D J Brooks,et al.  Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.

[60]  R A Holmes,et al.  Technetium-99 m d , l-HM-PAO : A New Rathopharmaceutical for SPECT Imaging of Regional CerebralBlood Perfusion , 2006 .

[61]  V J Cunningham,et al.  Central benzodiazepine receptors in malformations of cortical development: A quantitative study. , 2001, Brain : a journal of neurology.

[62]  C. Rowe,et al.  Postictal switch in blood flow distribution and temporal lobe seizures. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[63]  J. Duncan.  Positron Emission Tomography Receptor Studies , 1997, Advances in neurology.